In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.
Feature|Articles|May 15, 2026
5 Things to Pay Attention to During Women's Health Month
Author(s)Giuliana Grossi
Fact checked by: Christina Mattina
Women’s Health Month highlights major 2026 shifts in menopause care, brain health, abortion access, doula coverage, and wearable tech.
Advertisement
Advertisement
Women's health is experiencing a watershed moment in 2026. After decades of underinvestment and overlooked research gaps, the sector is seeing unprecedented clinical innovation and policy scrutiny. From how we treat menopause to how women access abortion care, the evidence landscape is shifting rapidly. Here are 5 critical trends that every health care stakeholder should be tracking.
Related to this article
Kirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.
Machine learning models for upper extremity soft tissue sarcoma had a C-index of 0.79 for local recurrence, similar to nomograms, in a 188-patient cohort.
Proposals to drop race questions from the 2030 census and end EEOC workforce reporting could leave gaps in national racial data.
AHIP's Jeanette Thornton explains where 2027 prior authorization standards fit in the affordability debate and what plans want from Congress.
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
In 459 patients with FLT3-ITD AML given high-dose anthracycline induction, a high allelic ratio was not linked to survival.
From 9.6 million US diabetic retinopathy cases to a new FDA warning on GLP-1s, here are 5 things to know about diabetic eye disease this November.
Advertisement
Advertisement